Benchling

Unlocking the power of biotech with modern software for modern science.

benchling.com

HQ: San Francisco, CA, USA

B2B

Company research

Public company, workplace, funding, and market signals

Updated Aug 16, 2026

Overview

Benchling is a cloud-based, biology-first AI platform for biotech R&D. It helps scientists design experiments, capture structured scientific data, and run AI agents/models in their workflows.

Primary product

Benchling R&D Cloud / AI platform for biotech R&D

Founded

2012

Headquarters

San Francisco, California, United States

Team size

501-1,000

Industry

Software Development

Sub-industry

Biotech R&D software / scientific data platform

Offices

Switzerland

United Kingdom

Business model

B2B SaaS

enterprise software

platform subscriptions

Funding

Stage

late stage private

Total raised

$412M

Latest round

Nov 2021

Latest amount

$100M

Series F

Nov 2021 · Franklin Templeton

$100M

Series E

Apr 2021

$200M

Seed

Apr 2016

Series C

Series D

Series G

Series A

Series B

People & investors

Leadership

Sajith Wickramasekara

CEO & Co-founder

Ashutosh Singhal

Co-founder

Miles Grimshaw

Board Director

Lauren DeVos

Head of Corp Dev & AI Partnerships

Leah Janoff

Head of SEC Reporting & Technical Accounting

Winnie Wong

Head of Product Design

Andrew Sielen

Head of Marketing Operations and Digital

Summer Frundel

Head of Business Recruiting

Abdelkader Batel

Head of Professional Services, EMEA

Pawan Patel

Leader, Central Europe

Founders

Ashu Singhal

Cofounder and President

Investors

Work & culture

Compensation

Public salary data surfaced by Exa includes software engineer salary ranges around USD 142,884/year, software engineering manager around USD 192,772/year, and senior operations manager around USD 133,052/year. Public employer-rating data suggests compensation is relatively solid versus other dimensions.

Product & market

Pricing

Enterprise SaaS / custom pricing likely; no public list pricing found

Differentiators

—Biology-first platform built specifically for biotech R&D
—Combines scientific data capture, collaboration, analytics, and AI workflows
—Used by over 200,000 scientists globally
—Deeply embedded in biotech and biopharma R&D workflows
—Acquisitions expanded into in vivo and AI workflow capabilities

Technology

OpenAI

React

PostgreSQL

Docker

Confluence

SQL

Kubernetes

GraphQL

Flask

Typescript

Ansible

AWS ECS

AWS Secrets Manager

HubSpot

Looker

Tableau

Mulesoft

Salesforce Sales Cloud

Salesforce CPQ

NetSuite

Customers

Sanofi

Moderna

Academic labs

More than half of the world's top 50 biopharma companies

Competitors

BenchSci

Dotmatics

LabVantage

Genedata

LabWare

PerkinElmer Informatics

TetraScience

SciCord

Scale & contact

Estimated revenue

~$50M annual revenue (Exa estimate)

Estimated monthly visits

1.5M

Traffic estimate as of Jun 2026

Signals & risks

Layoff

Apr 2023

Benchling laid off 74 employees, or 9% of its workforce.

Source

Acquisition

Feb 2022

Benchling acquired Overwatch Research to expand in vivo capabilities.

Source

Acquisition

Aug 2025

Benchling acquired ReSync Bio and Sphinx Bio to accelerate its AI roadmap.

Source

Latest news

Benchling company profile / public web presence

Exa · Jun 2026

Exa profile indicates 641 employees, ~$50M annual revenue, $412M total funding, San Francisco HQ, and web traffic around 1.54M monthly visits in June 2026.

Benchling and Lilly TuneLab Partner to Democratize Access to AI Models for Scientists Everywhere

Benchling News · Jan 2026

Strategic collaboration to bring Lilly TuneLab AI/ML models into Benchling workflows for more than 1,300 biotech companies; positions Benchling as a distribution platform for scientific AI.

Benchling Powers AI Model Access for Scientists With NVIDIA

Benchling News · Oct 2025

Benchling integrated NVIDIA NIM microservices into Benchling AI to provide direct access to GPU-optimized models in scientists' workflows.

Benchling Accelerates AI Roadmap with ReSync Bio and Sphinx Bio

Benchling News · Aug 2025

Benchling said it acquired ReSync Bio and Sphinx Bio to strengthen its AI roadmap and workflow automation capabilities.

Life sciences software startup Benchling lays off 9% of workforce

Reuters · Apr 2023

Reuters reported Benchling laid off 74 employees, or 9% of its workforce.

About Benchling Benchling Careers Careers Engineering blog GitHub Home Life at Benchling LinkedIn News Our Leadership

SourcesBenchling home Benchling news Benchling careers Benchling LinkedIn SEC filing (Form D)Reuters layoffs Reuters funding/listing